Ruste, Leonora L.

HRN: 06-70-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CEFUROXIME 1.5GM (VIAL)
10/09/2024
10/17/2024
IVT
1.5gm
Q 8 HRS
TMSAF; FDU
Waiting Final Action 
10/10/2024
METRONIDAZOLE 500MG (TAB)
10/10/2024
10/17/2024
IVT
500MG
Q 8 HRS
TMSAF; FDU
Waiting Final Action 
10/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2024
10/17/2024
IV
500mg
Every 8 Hours
Thickly Meconium Stained Amniotic Fluid; FDU
Waiting Final Action 
10/10/2024
CEFUROXIME 500MG (TAB)
10/10/2024
10/16/2024
PO
500mg
BID
Del To A Stillborn Macerated Baby
Waiting Final Action 
10/10/2024
METRONIDAZOLE 500MG (TAB)
10/10/2024
10/16/2024
PO
500mg
TID
Del To A Stillborn Macerated Baby
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: